Administering a purgative close to the time of colonoscopy is optimal for cleansing. The aim of this study was to compare the effi cacy and tolerability of morning-only ( AM -only) polyethylene glycol electrolyte solution (PEG-ELS) to split-dose ( PM / AM ) PEG-ELS for afternoon colonoscopy.
INTRODUCTION
Recently supported in a position paper by the American College of Gastroenterology, superior colon cleansing is more likely if at least some of a purgative is ingested on the day of colonoscopy ( 1 ) . Dayof-colon dosing can be achieved through two strategies -split ( PM / AM ) dosing in which part of the purgative is administered the night before colonoscopy and the remainder within ~ 6 h of the procedure, and morning-only ( AM -only) dosing in which the entire prep is taken on the day of colonoscopy ( 2 -5 ) . By linking the fi nal dose of purgative to the timing of colonoscopy, a greater chance of adequate cleansing is assured regardless of the time of colonoscopy.
Th ere may be some distinct advantages in using an AM -only dosing schedule in which colonoscopy, the prep and procedure, becomes a 1-day process. For one, it has the potential to minimize the prep ' s interference on the patient ' s ability to work and function the day before. Also, the impact on sleep may be diminished if no prep is consumed in the evening. In addition, patients may perceive AM -only dosing as better tolerated as the predictable adverse events occur " once " on the day of procedure as compared with over 2 days. Finally, this dosing regimen extends utilization of the endoscopy laboratory well into the aft ernoon ( 3 ) .
However, the potential disadvantages to AM -only dosing bear consideration. For some patients, such a regimen may not be practical for early morning procedures depending on the start time of the prep. Second, sodium phosphate cannot be used given the potential risk of administering a large dose over a short interval ( 6, 7 ) . Finally, though proven to be eff ective for AM -only dosing, 4 l polyethylene glycol-electrolyte solution (PEG-ELS) administered all in the morning might be poorly tolerated ( 8 ) .
Using a 2 l PEG-ELS solution which does not require supplemental laxatives and is already Food and Drug Administrationapproved for single ( PM -only) and split dosing ( PM / AM ), we evaluated the effi cacy, tolerance, and quality of life measures of AM -only dosing for aft ernoon colonoscopy. We hypothesized that AM -only 2 l PEG-ELS is as eff ective as PM / AM dosing for achieving adequate cleansing and detecting polyps, and furthermore that this administration schedule improves quality of life by interfering less with the day before colonoscopy.
METHODS
Th is was a prospective, randomized, investigator-blinded study, comparing AM -only with PM / AM PEG-ELS dosing for patients undergoing aft ernoon colonoscopy. All patients provided written informed consent. Th e study was conducted at a single site in Philadelphia, PA, and was approved by the institution ' s Institutional Review Board. It was registered at ClinicalTrials.gov ( http:// www.clinicaltrials.gov ), with identifi er NCT00929916.
Subjects
Patients 18 years of age or older, scheduled to undergo elective outpatient aft ernoon (12 PM or later) colonoscopy at a university hospital were eligible to participate. Exclusion criteria included pregnancy, breast feeding, known or suspected gastroparesis, chronic nausea or vomiting, bowel obstruction, hypomotility syndrome (pseudo-obstruction, megacolon, and so on), severe constipation ( ≤ 1 bowel movement a week), greater than 50 % colon resection, known glucose-6-phospate dehydrogenase defi ciency, PEG allergy, signifi cant psychiatric illness, or inability to provide informed consent.
Study design: randomization and protocol
Using a randomization schedule generated by the website http:// www.randomization.com , eligible patients were assigned to AMonly or PM / AM PEG-ELS by an investigator not involved in the colonoscopy procedure. A commercially available 2 l PEG-ELS containing sodium sulfate, sodium ascorbate, and ascorbic acid (MoviPrep, Salix Pharmaceuticals, Morrisville, NC) was used. Subjects were provided with a standard PEG-ELS kit and given detailed instructions regarding preparation of the PEG-ELS, the administration of their assigned schedule, and routine preparation for colonoscopy including diet, hydration, and when to begin fasting. Th e patient ' s endoscopist was not involved in the randomization process and remained blinded to the patient ' s preparation schedule for the duration of the study. All study procedures were performed by an attending physician; fellows did not participate.
Subjects randomized to PM / AM dose PEG-ELS were instructed to take the fi rst liter (250 ml every 15 min) plus 500 ml of clear liquids at 6 PM the night before colonoscopy, and the second liter 4 h before colonoscopy. Subjects assigned to AM -only administration took the fi rst 1 l dose 7 h before colonoscopy and the second 1 l dose 4 h before colonoscopy.
Diet instructions were identical for both study groups. On the day before colonoscopy, patients were permitted a low-residue breakfast (before 10 AM ). Patients received instructions regarding a low-residue diet, including a list of acceptable and unacceptable foods ( Supplementary Appendix A online). Aft er 10 AM on the day before colonoscopy, patients were allowed clear liquids until 2.5 h before colonoscopy, at which point they took nothing further by mouth except for medications with sips of water.
All subjects were called by an investigator who was not performing the colonoscopy within 1 week of their scheduled procedure and reminded about their colonoscopy appointment and specifi c preparation. On the day of their aft ernoon colonoscopy, patients arrived 1 h before their scheduled procedure and met with an investigator who was not performing the colonoscopy. Patients completed several questionnaires evaluating compliance, tolerance, satisfaction, sleep, and work and productivity for the previous day. Tolerance was measured using a 10-point Likert scale, and patients rated side eff ects (nausea, vomiting, abdominal pain, lightheadedness, bloating) from 0 (none) to 10 (severe). Sleep quantity was measured by comparing the average number of hours the patient normally sleeps to the number of hours they slept the night before colonoscopy. Sleep quality was rated on a 5-point scale: very poor, poor, average, good, and very good. Finally, work and productivity were measured using questions adapted from Th e Health and Labour Questionnaire ( 9 ) . Patients rated how much their work, daily activities, and overall productivity were impaired by the preparation. Patients who went to work the day before responded with strongly agree, agree, disagree, or strongly disagree to statements focused on whether they had trouble concentrating, had to work alone, could not do some work, or needed co-workers to do some work. Patients who did not have work the day before colonoscopy rated how much the preparation aff ected their household work, shopping and errands, child care, and other chores. A physician or registered nurse performed a safety assessment that included vital signs and physical examination. All patients got monitored anesthesia care with propofol-based sedation administered by a certifi ed registered nurse anesthetist.
During the procedure, an investigator assisted the endoscopist in recording total procedure and withdrawal time (excluding interventions), cecal intubation, fi ndings, and specifi c information regarding polyps, including the number, location, size, morphology, and method of excision. At the conclusion of the procedure, the endoscopist graded the quality of preparation for the whole colon and the right colon (excellent, good, fair, or poor) and estimated the amount of fl ushing required (none, < 50, 50 -100, or > 100 cc). A descriptor of each preparation grade was available for the endoscopist to review at the time of assigning the grade ( Supplementary Appendix B ) . When fi nal pathology reports became available for each patient, an investigator not involved in performing the colonoscopy recorded the following for each polyp: pathologic size, histology (hyperplastic, adenomatous, cancer, other), and additional histologic features for adenomas including grade of dysplasia (low grade, high grade) and the presence of a villous or serrated component.
Masking
To ensure blinding, patients were instructed by an investigator not to discuss their preparation assignment with the endoscopist. In addition, all preparation instructions were given in a closed exam room without the endoscopist present. At the time of colonoscopy, the endoscopists documented whether they had remained blind to the patients ' preparation through completion of the colonoscopy and grading of the prep.
Outcome measures
Th e primary trial end point was the dichotomous index of prep quality (adequate vs. inadequate) for the whole colon. Adequate was defi ned as a good or excellent prep, and inadequate was defi ned as a fair or poor prep. Th e adequacy of cleansing for the right colon and the need for fl ush were secondary end points of prep quality. Additional secondary end points included prep completion, side eff ects (nausea, vomiting, abdominal pain, bloating, light-headedness), measures of quality of life (overall satisfaction, sleep quality, interference with work and overall productivity), and colonoscopy fi ndings.
Statistical analysis
Th e analyses of the end points of prep quality and fi ndings evaluated non-inferiority of the AM -only prep compared with the PM / AM prep, with prespecifi ed margins. For prep quality, we expected about 90 % of the cases in the PM / AM prep to be judged adequate, and the non-inferiority margin was set at − 15 % (that is, the adequacy rate of the AM -only prep should not be lower than that of the PM / AM prep by more than 15 % ). Th e study was designed to have 82 % power to establish non-inferiority (using a one-sided test with α = 0.05 and a target sample size of 110). Th e assumptions and prespecifi ed non-inferiority margins for fl ush and the colonoscopy fi nding end points are summarized in Table 1 . For each end point, we computed diff erences between the two groups, along with a one-sided 95 % confi dence interval (CI) and a one-sided P value against the non-inferiority margin (with a signifi cant P value establishing non-inferiority). For the dichotomous end points, exact procedures were used.
Th e analyses of the side eff ects and measures of quality of life tested superiority of the AM -only prep compared with the PM / AM prep. Fisher ' s exact test was used for categorical variables, and t -test or the non-parametric Kruskall -Wallis test was used for continuous variables (all tests were two-sided, with α = 0.05, with signifi cant P values establishing a diff erence between the two groups). All subjects were included in the group that they were assigned to, irrespective of whether (or when) they took their preparation doses. However, subjects who canceled their colonoscopy aft er randomization did not provide any data and consequently were excluded from all analyses. Th e analyses were carried out in SAS 9.2 (SAS Institute, Cary, NC) and StatXact 8 (Cytel, Cambridge, MA).
RESULTS

Participant fl ow and follow-up
From October 2008 through April 2009, 125 patients referred for outpatient colonoscopy were initially randomized to AM -only or PM / AM prep (See Figure 1 fl ow diagram) . However, 9 patients withdrew before taking any prep (5 patients canceled their procedures and were unable to reschedule within the study time period, 1 patient required a morning procedure because of co-morbid conditions, 1 patient preferred a morning procedure, and 2 patients did not want to continue participating in the study), and therefore the analyses included 116 patients, of whom 62 received AM -only prep and 54 received PM / AM prep. One patient in the AM -only group experienced nausea / vomiting and did not undergo colonoscopy but was included in the analyses of side eff ects and quality of life. Th e 115 procedures were performed by two endoscopists (with 110 of them performed by the study ' s principal investigator, D.K.). Endoscopist masking was maintained for all but one case. Table 2 summarizes the characteristics of the study patients. Compared with PM / AM prep, the AM -only group had a somewhat greater number of women, and relatively fewer patients with a history of gastroesophageal refl ux disease (GERD) and use of acid suppression medications, as well as cardiovascular disease.
Prep quality
Prep quality was measured for the 115 patients who underwent colonoscopy and is summarized in Table 3 . Th e colonoscopy was completed in all but one patient in the AM -only group whose procedure was aborted because of poor prep. Th e whole colon prep was adequate for 56 / 61 (91.8 % ) patients in the AM -only group vs. 51 / 54 (94.4 % ) patients in the PM / AM group (95 % lower confi dence limit, LCL, for the diff erence = − 11.3 % , non-inferiority . Th e need for any fl ushing during the colonoscopy was similar between the study groups (26 / 61, 43 % , in the AM -only group vs. 28 / 54, 52 % , in the PM / AM group, 95 % upper confi dence limit for the diff erence = 6.4 % , non-inferiority P = 0.001, Table 3 ).
Prep completion, side effects, and quality of life ( Table 4 ). Aft er controlling for age, sex, history of cardiovascular disease, and use of acid suppression medications by logistic regression, the two groups remained diff erent for the incidence of abdominal pain but not for light-headedness (adjusted P = 0.045 and 0.152, respectively). However, the severity of abdominal pain between the two groups was not signifi cantly diff erent ( P = 0.144). One patient in the AM -only group who was severely obese (body mass index = 40 kg / m 2 ) aspirated during the procedure, was observed in the hospital for 24 h, and treated with 1 week of oral antibiotics.
Duration of sleep the night before colonoscopy was not significantly diff erent between the two groups ( P = 0.675, Table 4 ), but the AM -only group had signifi cantly better sleep quality ( P = 0.007, Table 4 ). About a fi ft h of the patients in the AM -only group rated their sleep as " very good, " whereas this was the case for only a single patient in the PM / AM group. Th e proportion of patients that slept at least 80 % of their typical hours was not signifi cantly diff erent between the groups ( P = 0.675, Table 4 ). grade dysplasia, villous histology, or size ≥ 1 cm), or cancer. Compared with the PM / AM group, the AM -only group had an average of 0.24 more fi ndings per patient (mean = 0.70 in AM -only vs. 0.46 in PM / AM , 95 % LCL for diff erence = − 0.12, non-inferiority P = 0.047) and a greater detection rate for fi ndings (22 / 60, 37 % , vs. 14 / 54, 26 % , 95 % LCL for diff erence = − 3.9, non-inferiority P = 0.038). Th e AM -only group also had a somewhat higher detection rate with respect to high-risk adenomas or cancer than the In the subset of patients who went to work the day before colonoscopy, the AM -only group reported less interference with their ability to work ( P = 0.019, Table 4 ). Overall, satisfaction and the prep ' s interference with overall productivity in everyday life were not signifi cantly diff erent between the two groups ( P = 0.975 and 0.687, respectively, Table 4 ). Th e majority of patients favored repeating the same preparation in the future (51 / 62, 82 % , in the AM -only group vs. 43 / 54, 80 % , in the PM / AM group, P = 0.814), and most maintained this preference even when the alternative prep schedule was explained and off ered as an option (46 / 62, 74 % , in the AM -only group vs. 37 / 54, 69 % , in the PM / AM group, P = 0.541). Table 5 summarizes polyp and adenoma / cancer detection. Th e average number of polyps per patient was 0.67 higher in the AMonly group (mean = 1.57 in AM -only vs. 0.94 in PM / AM , 95 % LCL for diff erence = 0.04, non-inferiority P = 0.007). Positive pathology fi ndings included " low-risk " adenomas (low-grade dysplasia or serrated histology with size < 1 cm), " high-risk " adenomas (high- Only among patients who went to work (22 in PM / AM group and 27 in AM -only group).
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PM / AM group (8 / 60, 13 % , vs. 6 / 54, 11 % ), but the study precision was not suffi cient to establish non-inferiority on such fi ndings (95 % LCL for diff erence = − 8.7, non-inferiority P = 0.282).
DISCUSSION
An ideal colon purgative is safe, eff ective, and well tolerated. Despite more than 14 million colonoscopies being performed each year, the historic rates for adequate cleansing are unacceptably low and range from 70 to 82 % ( 10 -13 ). Recent studies have shown that ingesting at least part of the purgative on the day of colonoscopy and coordinating the fi nal dose of purgative with the start time of colonoscopy is more likely to result in adequate colon cleansing ( 2 -5 ) . Generally, this is accomplished by splitting the purgative between the evening prior and the morning of colonoscopy. Th is study expands the options for patients by demonstrating that ingestion of a low volume PEG-ELS prep entirely on the day of colonoscopy is as good as a split dose schedule. Purgative ingestion entirely on the day of colonoscopy successfully met the predefi ned quality end points, as compared with traditional split dosing. First and foremost, the rate of adequate cleansing for the whole colon was similarly high in the two groups (92 % in the AM -only group and 94 % in the PM / AM group). Adequate cleansing of the right colon, typically more diffi cult, was also similar and very high in both study arms (93 vs. 92 % , respectively). Th is rate of success, much higher than seen in retrospective studies oft en using a long interval between prep and procedure, also affi rms the importance of dosing the prep close to the time of colonoscopy ( 10 -13 ). A non-inferiority design with respect to the primary end point of cleansing was used because split dosing typically produces a high level of adequate bowel preparation. Importantly, the trial results excluded big defi ciencies in quality of the morning-only prep compared with the traditional split dosing. However, even though the study established non-inferiority using a margin of − 15 % , it is possible that the PM / AM prep may have somewhat better quality (although probably not by more than 10 percentage points or so). A further measure of colon cleanliness, the need for fl ushing, was also not inferior in the AM -only group (and in fact appeared somewhat better), compared with the PM / AM group. Finally, polyp detection and pathology fi ndings (any adenoma or cancer) in the AM -only group were not less common than the PM / AM group (and the former even appeared more sensitive than the latter). Th e CIs for these end points excluded any large diff erences in favor of the PM / AM prep. For the specifi c fi nding of high-risk adenomas or cancer, the AM -only group appeared slightly more sensitive than the PM / AM group, but the study failed to establish non-inferiority. Th is is probably due to a type II error as the study was underpowered to establish non-inferiority on an end point with such a low event rate.
Results on several adverse events and quality of life measures were mixed. Abdominal pain occurred signifi cantly less oft en with AM -only dosing. Th e study failed to establish superiority of the AM -only dosing on other side eff ects, although some of those were somewhat less common in the AM -only group. Th e AM -only prep had better quality of sleep, but there was no diff erence between the two preps in duration of sleep. Perhaps apparent benefi t on sleep quality was negated by the need to arise early in the AMonly group. For instance, a 12 PM (earliest start time) colonoscopy required the prep begin at 5 AM for the AM -only group and 8 AM for the PM / AM group.
With respect to work, of patients who worked outside the home, only 56 % in the PM / AM group and 64 % in the AM -only group actually went to work the day before colonoscopy. Th eoretically, PM / AM dosing should have little impact on the workday, and AM -only dosing none. All patients were permitted a low-residue breakfast up to 10 AM , and then clear liquids up to 2.5 h before the colonoscopy, but this restriction may have been enough to impact the workday. Among those who did go to work, patients in the AM -only group reported signifi cantly less interference in the workday. Th e vast majority of patients in both groups found little to no impact of the preparation on overall productivity. adenoma or cancer detection. Furthermore, AM -only dosing was superior to PM / AM dosing with respect to some quality of life measures, as well as the incidence of prep-associated abdominal pain. Th ese results support the notion that timing the last dose of purgative relative to the start time of colonoscopy results in a high rate of adequate colon cleansing, regardless of whether the prep is started the night before or on the morning of colonoscopy. AM -only dosing is a viable option that moves the process of colonoscopy -prep and procedure -toward becoming a one-day procedure. While the paradigm has been for colonoscopy to be performed in the morning, linking the administration of the prep to the time of the procedure for both AM -only and PM / AM dosing may make late morning and aft ernoon colonoscopy equally or more attractive to patients in the future.
Satisfaction was high for both groups and did not vary signifi cantly between the two prep regimens. Several factors, in addition to dosing the purgative close to the time of colonoscopy, may have contributed to a high rate of adequacy for both groups. First, low volume PEG-ELS is better tolerated than 4 l PEG purgatives, and likely leads to greater compliance ( 14, 15 ) . In addition, patients were carefully educated and supported throughout the precolonoscopy period. Th is has been shown to boost the success rate of colon preparation ( 16 ) . Th e investigator consenting the patient provided detailed instructions on diet, purgative preparation and administration, and the possible side eff ects that might be experienced. With respect to diet, this was not highly restrictive as we chose a diet consisting of a low-residue breakfast before 10 AM on the day prior followed by clears up to 2.5 h before colonoscopy. Th ough many physicians order a clear liquid diet for 24 h, several studies support a less restrictive diet ( 4, 17, 18 ) .
A member of the research team uninvolved in grading the preparation called patients within 1 week of their scheduled procedure to remind them about their procedure, review their specifi c prep, and provide a contact number for patients to call for prep-related questions. Most patients undergoing routine colonoscopy do not have this degree of attention and support.
Another consideration is that all but fi ve colonoscopies were performed by one of the two endoscopists involved in this study. Th ough this should not have aff ected the non-inferiority results, as the endoscopists were blinded to prep, if the predominant grader was " lenient, " colon grades could have all been infl ated and resulted in overall high adequacy rates. Finally, these data likely only apply to patients undergoing aft ernoon colonoscopy.
One patient in the AM -only group aspirated while under moderate sedation and developed aspiration pneumonia. Both groups of patients in the study presented herein were asked to complete the second dose of PEG-ELS 4 h before their scheduled procedure time. Aspiration, though rare, is serious and has not been reported in several studies that have specifi cally evaluated PEG-ELS dosing on the day of colonoscopy ( 2 -5,8 ) . Large published series of patients receiving propofol-based anesthesia for endoscopy have found aspiration to be a rare event. In one, of 2,000 healthy patients undergoing endoscopic procedures with nurse-administered propofol, there were fi ve patients whose oxygen saturation fell to below 85 % ( 19 ) . Several conditions may be associated with increased incidence of pulmonary aspiration during general anesthesia, including extremes of age, male gender, pregnancy, diffi cult airway management, and factors that decrease gastric emptying, such as concurrent opioid administration, gastrointestinal obstruction or dysfunction, obesity, or depressed level of consciousness ( 20, 21 ) . Our patient who aspirated had no obvious risk factors for aspiration other than a body mass index of 40 kg / m 2 , classifying her as morbidly obese. In patients who are high risk for aspiration, measures such as increasing the interval between the second purgative dose and the time of colonoscopy and / or reducing the prep volume consumed the day of colonoscopy may be prudent.
In conclusion, our study showed that AM -only and PM / AM administration strategies for PEG-ELS are clinically equivalent with respect to cleansing effi cacy, need for fl ushing, polyp detection, and
